Utilization and Adverse Outcomes of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation in the United States
Authors:
- Apurva O. BadhekaABApurva O. Badheka
- Ankit ChothaniACAnkit Chothani
- Kathan MehtaKMKathan Mehta
- Nileshkumar J. PatelNPNileshkumar J. Patel
- Abhishek DeshmukhADAbhishek Deshmukh
- Michael HoosienMHMichael Hoosien
- Neeraj ShahNSNeeraj Shah
- Vikas SinghVSVikas Singh
- Peeyush GroverPGPeeyush Grover
- Ghanshyambhai T. SavaniGSGhanshyambhai T. Savani
- Sidakpal S. PanaichSPSidakpal S. Panaich
- Ankit RathodARAnkit Rathod
- 1 February 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 8 (1) , 42-48
Abstract
Background—: Safety data on percutaneous left atrial appendage closure arises from centers with considerable expertise in the procedure or from clinical trial, which might not be reproducible in clinical practice. We sought to estimate the frequency and predictors of adverse outcomes and costs of percutaneous left atrial appendage closure procedure in the US. Methods and Results—: The data were obtained from the Nationwide Inpatient Sample from the years 2006 to 2010. The Nationwide Inpatient Sample is the largest all-payer inpatient data set in the US. Complications were calculated using patient safety indicators and International Classification of Diseases -Ninth Revision, Clinical Modification codes. Annual hospital volume was calculated using unique hospital identifiers. Weights provided by the Nationwide Inpatient Sample were used to generate national estimates. A total of 268 (weighted=1288) procedures were analyzed. The overall composite rate of mortality or any adverse event was 24.3% (65), with 3.4% patients required open cardiac surgery after procedure. Average length of stay was 4.61±1.05 days and cost of care was 26 024±34 651. Annual hospital procedural volume was significantly associated with reduced complications and mortality (every unit increase: odds ratio, 0.89; 95% confidence interval, 0.85–0.94; P P P <0.001). Conclusions—: Our study demonstrates that the frequency of inhospital adverse outcomes associated with percutaneous left atrial appendage closure is higher in the real-world population than in clinical trials. We also demonstrate that higher annual hospital volume is associated with safer procedures, with lower length of stay and cost.Keywords
This publication has 14 references indexed in Scilit:
- Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindications to Anticoagulation TherapyJACC, 2013
- Percutaneous Left Atrial Appendage Suture Ligation Using the LARIAT Device in Patients With Atrial FibrillationJACC, 2013
- Determinants of Adverse Events in Vascular SurgeryJournal of the American College of Surgeons, 2012
- Effect of Joint National Committee VII Report on Hospitalizations for Hypertensive Emergencies in the United StatesThe American Journal of Cardiology, 2011
- New Anticoagulants for Prevention of Stroke in Patients with Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2011
- Safety of Percutaneous Left Atrial Appendage ClosureCirculation, 2011
- A Prospective Comparison of Cardiac Imaging Using Intracardiac Echocardiography With Transesophageal Echocardiography in Patients With Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2010
- Use of intracardiac echocardiography to guide implantation of a left atrial appendage occlusion device (PLAATO)Heart Rhythm, 2007
- Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillationThe Annals of Thoracic Surgery, 1996
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992